Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

SPARC is required for the maintenance of glucose homeostasis and insulin secretion in mice.

Atorrasagasti C, Onorato A, Gimeno ML, Andreone L, Garcia M, Malvicini M, Fiore E, Bayo J, Perone MJ, Mazzolini G.

Clin Sci (Lond). 2019 Jan 9. pii: CS20180714. doi: 10.1042/CS20180714. [Epub ahead of print]

PMID:
30626728
2.

4Mu Decreases CD47 Expression on Hepatic Cancer Stem Cells and Primes a Potent Antitumor T Cell Response Induced by Interleukin-12.

Rodríguez MM, Fiore E, Bayo J, Atorrasagasti C, García M, Onorato A, Domínguez L, Malvicini M, Mazzolini G.

Mol Ther. 2018 Dec 5;26(12):2738-2750. doi: 10.1016/j.ymthe.2018.09.012. Epub 2018 Sep 18.

PMID:
30301668
3.

A Tricin Derivative from Deschampsia antarctica Desv. Inhibits Colorectal Carcinoma Growth and Liver Metastasis through the Induction of a Specific Immune Response.

Malvicini M, Gutierrez-Moraga A, Rodriguez MM, Gomez-Bustillo S, Salazar L, Sunkel C, Nozal L, Salgado A, Hidalgo M, Lopez-Casas PP, Novella JL, Vaquero JJ, Alvarez-Builla J, Mora A, Gidekel M, Mazzolini G.

Mol Cancer Ther. 2018 May;17(5):966-976. doi: 10.1158/1535-7163.MCT-17-0193. Epub 2018 Feb 26.

PMID:
29483221
4.
5.

Involvement of hepatic macrophages in the antifibrotic effect of IGF-I-overexpressing mesenchymal stromal cells.

Fiore E, Malvicini M, Bayo J, Peixoto E, Atorrasagasti C, Sierra R, Rodríguez M, Gómez Bustillo S, García MG, Aquino JB, Mazzolini G.

Stem Cell Res Ther. 2016 Nov 22;7(1):172.

6.

IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without affecting tumor aggressiveness.

Bayo J, Real A, Fiore EJ, Malvicini M, Sganga L, Bolontrade M, Andriani O, Bizama C, Fresno C, Podhajcer O, Fernandez E, Gidekel M, Mazzolini GD, García MG.

Oncotarget. 2016 Jun 25;8(46):80235-80248. doi: 10.18632/oncotarget.10288. eCollection 2017 Oct 6.

7.

Tumor Microenvironment Remodeling by 4-Methylumbelliferone Boosts the Antitumor Effect of Combined Immunotherapy in Murine Colorectal Carcinoma.

Malvicini M, Fiore E, Ghiaccio V, Piccioni F, Rizzo M, Olmedo Bonadeo L, García M, Rodríguez M, Bayo J, Peixoto E, Atorrasagasti C, Alaniz L, Aquino J, Matar P, Mazzolini G.

Mol Ther. 2015 Sep;23(9):1444-55. doi: 10.1038/mt.2015.112. Epub 2015 Jun 24.

8.

4-methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis.

Piccioni F, Fiore E, Bayo J, Atorrasagasti C, Peixoto E, Rizzo M, Malvicini M, Tirado-González I, García MG, Alaniz L, Mazzolini G.

Glycobiology. 2015 Aug;25(8):825-35. doi: 10.1093/glycob/cwv023. Epub 2015 Apr 16.

PMID:
25882295
9.

Combined therapy for gastrointestinal carcinomas: exploiting synergies between gene therapy and classical chemo-radiotherapy.

Malvicini M, Aquino JB, Mazzolini G.

Curr Gene Ther. 2015;15(2):151-60. Review.

PMID:
25537776
10.

Mesenchymal stromal cells engineered to produce IGF-I by recombinant adenovirus ameliorate liver fibrosis in mice.

Fiore EJ, Bayo JM, Garcia MG, Malvicini M, Lloyd R, Piccioni F, Rizzo M, Peixoto E, Sola MB, Atorrasagasti C, Alaniz L, Camilletti MA, Enguita M, Prieto J, Aquino JB, Mazzolini G.

Stem Cells Dev. 2015 Mar 15;24(6):791-801. doi: 10.1089/scd.2014.0174. Epub 2014 Dec 3.

11.

Low molecular weight hyaluronan-pulsed human dendritic cells showed increased migration capacity and induced resistance to tumor chemoattraction.

Rizzo M, Bayo J, Piccioni F, Malvicini M, Fiore E, Peixoto E, García MG, Aquino JB, Gonzalez Campaña A, Podestá G, Terres M, Andriani O, Alaniz L, Mazzolini G.

PLoS One. 2014 Sep 19;9(9):e107944. doi: 10.1371/journal.pone.0107944. eCollection 2014.

12.

Human umbilical cord perivascular cells exhibited enhanced migration capacity towards hepatocellular carcinoma in comparison with bone marrow mesenchymal stromal cells: a role for autocrine motility factor receptor.

Bayo J, Fiore E, Aquino JB, Malvicini M, Rizzo M, Peixoto E, Alaniz L, Piccioni F, Bolontrade M, Podhajcer O, Garcia MG, Mazzolini G.

Biomed Res Int. 2014;2014:837420. doi: 10.1155/2014/837420. Epub 2014 Jul 23.

13.

Increased migration of human mesenchymal stromal cells by autocrine motility factor (AMF) resulted in enhanced recruitment towards hepatocellular carcinoma.

Bayo J, Fiore E, Aquino JB, Malvicini M, Rizzo M, Peixoto E, Andriani O, Alaniz L, Piccioni F, Bolontrade M, Podhajcer O, Garcia MG, Mazzolini G.

PLoS One. 2014 Apr 15;9(4):e95171. doi: 10.1371/journal.pone.0095171. eCollection 2014.

14.

Lack of the matricellular protein SPARC (secreted protein, acidic and rich in cysteine) attenuates liver fibrogenesis in mice.

Atorrasagasti C, Peixoto E, Aquino JB, Kippes N, Malvicini M, Alaniz L, Garcia M, Piccioni F, Fiore EJ, Bayo J, Bataller R, Guruceaga E, Corrales F, Podhajcer O, Mazzolini G.

PLoS One. 2013;8(2):e54962. doi: 10.1371/journal.pone.0054962. Epub 2013 Feb 11.

15.

Chemoimmunotherapy for advanced gastrointestinal carcinomas: A successful combination of gene therapy and cyclophosphamide.

Malvicini M, Piccioni F, Bayo J, Fiore E, Atorrasagasti C, Alaniz L, Garcia M, Aquino JB, Gidekel M, Matar P, Mazzolini G.

Oncoimmunology. 2012 Dec 1;1(9):1626-1628.

16.

Single low-dose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in mice.

Malvicini M, Alaniz L, Bayo J, Garcia M, Piccioni F, Fiore E, Atorrasagasti C, Aquino JB, Matar P, Mazzolini G.

Oncoimmunology. 2012 Oct 1;1(7):1038-1047.

17.

Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice.

Piccioni F, Malvicini M, Garcia MG, Rodriguez A, Atorrasagasti C, Kippes N, Piedra Buena IT, Rizzo MM, Bayo J, Aquino J, Viola M, Passi A, Alaniz L, Mazzolini G.

Glycobiology. 2012 Mar;22(3):400-10. doi: 10.1093/glycob/cwr158. Epub 2011 Oct 28.

PMID:
22038477
18.

Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.

Garcia MG, Bayo J, Bolontrade MF, Sganga L, Malvicini M, Alaniz L, Aquino JB, Fiore E, Rizzo MM, Rodriguez A, Lorenti A, Andriani O, Podhajcer O, Mazzolini G.

Mol Pharm. 2011 Oct 3;8(5):1538-48. doi: 10.1021/mp200137c. Epub 2011 Aug 19.

PMID:
21770423
19.

Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma.

Alaniz L, Rizzo M, Garcia MG, Piccioni F, Aquino JB, Malvicini M, Atorrasagasti C, Bayo J, Echeverria I, Sarobe P, Mazzolini G.

Cancer Immunol Immunother. 2011 Oct;60(10):1383-95. doi: 10.1007/s00262-011-1036-0. Epub 2011 Jun 3.

PMID:
21638126
20.

Reversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-12.

Malvicini M, Ingolotti M, Piccioni F, Garcia M, Bayo J, Atorrasagasti C, Alaniz L, Aquino JB, Espinoza JA, Gidekel M, Scharovsky OG, Matar P, Mazzolini G.

Mol Oncol. 2011 Jun;5(3):242-55. doi: 10.1016/j.molonc.2011.03.007. Epub 2011 Apr 5.

21.

SPARC downregulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-β1 and PDGF.

Atorrasagasti C, Aquino JB, Hofman L, Alaniz L, Malvicini M, Garcia M, Benedetti L, Friedman SL, Podhajcer O, Mazzolini G.

Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G739-48. doi: 10.1152/ajpgi.00316.2010. Epub 2011 Feb 10.

22.

[Cancer immunotherapy. Importance of overcoming immune suppression].

Malvicini M, Puchulo G, Matar P, Mazzolini G.

Medicina (B Aires). 2010;70(6):565-70. Review. Spanish.

PMID:
21163748
23.

A novel synergistic combination of cyclophosphamide and gene transfer of interleukin-12 eradicates colorectal carcinoma in mice.

Malvicini M, Rizzo M, Alaniz L, Piñero F, García M, Atorrasagasti C, Aquino JB, Rozados V, Scharovsky OG, Matar P, Mazzolini G.

Clin Cancer Res. 2009 Dec 1;15(23):7256-65. doi: 10.1158/1078-0432.CCR-09-1861. Epub 2009 Nov 17.

24.

Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells.

Atorrasagasti C, Malvicini M, Aquino JB, Alaniz L, Garcia M, Bolontrade M, Rizzo M, Podhajcer OL, Mazzolini G.

Int J Cancer. 2010 Jun 1;126(11):2726-40. doi: 10.1002/ijc.24966.

25.

Immunotherapy for liver tumors: present status and future prospects.

Matar P, Alaniz L, Rozados V, Aquino JB, Malvicini M, Atorrasagasti C, Gidekel M, Silva M, Scharovsky OG, Mazzolini G.

J Biomed Sci. 2009 Mar 6;16:30. doi: 10.1186/1423-0127-16-30. Review.

26.

Low molecular weight hyaluronan inhibits colorectal carcinoma growth by decreasing tumor cell proliferation and stimulating immune response.

Alaniz L, Rizzo M, Malvicini M, Jaunarena J, Avella D, Atorrasagasti C, Aquino JB, Garcia M, Matar P, Silva M, Mazzolini G.

Cancer Lett. 2009 Jun 8;278(1):9-16. doi: 10.1016/j.canlet.2008.12.029. Epub 2009 Jan 29.

PMID:
19185418
27.

[Reconstruction of the teeth with preprosthetic aspects].

Malvicini M, Bianchi F.

Dent Cadmos. 1987 Feb 15;55(2):67-72. Italian. No abstract available.

PMID:
3308534
28.

[Evaluation of the use of a photopolymerizing material in the posterior quadrant].

Bianchi F, Malvicini M.

Dent Cadmos. 1986 Jul 15;54(12):85-9. Italian. No abstract available.

PMID:
3464480
29.

[Progress in conservative dentistry: dentin adhesives. II. Treatment of vital teeth].

Bianchi F, Malvicini M.

Dent Cadmos. 1985 Oct 15;53(15):61-6. Italian. No abstract available.

PMID:
3916362
30.

[1960-1985: 22 years' experience with bio-alloplastic implants].

Silvestrini-Biavati M, Malvicini M.

Parodontol Stomatol (Nuova). 1985 Sep-Dec;24(3):57-65. Italian. No abstract available.

PMID:
3939373
31.

[The rider-design bio-alloplastic hetero-transplant].

Malvicini M.

Parodontol Stomatol (Nuova). 1985 Sep-Dec;24(3):53-5. Italian. No abstract available.

PMID:
3939372
32.

[The basket-design bio-alloplastic hetero-transplant].

Malvicini M.

Parodontol Stomatol (Nuova). 1985 Sep-Dec;24(3):49-52. Italian. No abstract available.

PMID:
3939371
33.

[Prevention of caries in fixed dentures].

Malvicini M, Bianchi F.

Parodontol Stomatol (Nuova). 1985 Sep-Dec;24(3):43-8. Italian. No abstract available.

PMID:
3939370
34.

[Progress in conservative dentistry: dentin adhesives. I: The treatment of devitalized teeth].

Bianchi F, Malvicini M.

Dent Cadmos. 1985 Jul 15;53(12):65-70. Italian. No abstract available.

PMID:
3867526
35.

[3 methods for the restoration of teeth for prosthetic finishing].

Bianchi F, Malvicini M.

Dent Cadmos. 1985 Jun 30;53(11):75-6, 79-80, 83-8. Italian. No abstract available.

PMID:
3912212
36.

[Mesial three-quarter semi-crowns on molars (1)].

Malvicini M.

Parodontol Stomatol (Nuova). 1984 Jan-Mar;23(1):9-13. Italian. No abstract available.

PMID:
6441921
37.

[Semi-crown with 3 lingual grooves (5)].

Malvicini M.

Parodontol Stomatol (Nuova). 1984 Jan-Mar;23(1):29-32. Italian. No abstract available.

PMID:
6441913
38.

[Semi-crown with 3 grooves (4)].

Malvicini M.

Parodontol Stomatol (Nuova). 1984 Jan-Mar;23(1):25-8. Italian. No abstract available.

PMID:
6441912
39.

[Clinical use of mesial and distal three-quarter semi-crowns (3)].

Malvicini M.

Parodontol Stomatol (Nuova). 1984 Jan-Mar;23(1):19-23. Italian. No abstract available.

PMID:
6441910
40.

[Distal three-quarter semi-crowns on molars (2)].

Malvicini M.

Parodontol Stomatol (Nuova). 1984 Jan-Mar;23(1):15-8. Italian. No abstract available.

PMID:
6441908

Supplemental Content

Loading ...
Support Center